Medi5752 (Volrustomig), A Novel Pd-1/Ctla-4 Bispecific Antibody, In The First-Line (1L) Treatment Of 65 Patients (Pts) With Advanced Clear Cell Renal Cell Carcinoma (Arcc)
MEDI-5752
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Medi5752 (Volrustomig), A Novel Pd-1/Ctla-4 Bispecific Antibody, In The First-Line (1L) Treatment Of 65 Patients (Pts) With Advanced Clear Cell Renal Cell Carcinoma (Arcc) ### Output: MEDI-5752